Coming Off a GLP-1: Maintenance and the Rebound Question

The question underneath all the other questions

Every woman I have talked to about these drugs arrives, sooner or later, at the same quiet fear. Not the nausea. Not the injections. Not even the cost, though that one is loud. The fear is this: what happens when I stop? It is the question underneath all the other questions, and it deserves a straight answer rather than a reassuring one. Because the honest answer is that stopping a GLP-1 is not like finishing a course of antibiotics. For most people, the medication is doing a job that the body resumes doing its own way the moment the drug leaves — and that resumption has a name in the search bars: rebound weight.

Let us report it plainly, then talk about what to actually do with it.

What the withdrawal trials show

The evidence here is unusually clean, because researchers ran the exact experiment we all worry about: they took people who had lost weight on a GLP-1 and stopped the drug.

In the STEP 1 trial extension, participants who had lost weight on semaglutide came off it. Over the year that followed, they regained about two-thirds of the weight they had lost, and much of the improvement in blood pressure, blood sugar, and cholesterol drifted back toward where it started¹. In STEP 4, people who had already lost weight were split: those who kept taking semaglutide continued losing, while those switched to placebo began climbing back². The tirzepatide story is the same shape — in SURMOUNT-4, people who continued the drug held their loss, while those who stopped regained a substantial share of it³.

Three trials, two molecules, one lesson: these drugs work while you take them. They are not a bridge you cross and leave behind. That is not a flaw in the medicine — it is the nature of obesity as a chronic, relapsing condition. We do not expect blood-pressure pills to keep working after we stop them either. But it reframes the entire decision, and it should reframe yours.

Rebound is not willpower failing. It is biology resuming. Naming it correctly is the first step to planning around it.

Why the weight comes back

The rebound is not a moral event, and treating it as one is how good women end up ashamed of their own physiology. GLP-1 medications work in large part by turning down appetite and the relentless food-noise that governs how much we eat. Remove the drug and that signaling returns to its old set point. Hunger comes back. The body, which experiences weight loss as a threat to be corrected, nudges metabolism and appetite toward restoring what it lost. This is the same machinery that has defeated diets for a century — and it is precisely the machinery the medication was quieting.

So when the weight returns after stopping, it is not that you "failed to keep it off." It is that the thing keeping it off was removed. Naming that correctly is not permission to stay on a drug forever; it is the only honest starting point for deciding whether, when, and how to come off.

The mother's version: a planned pause

For mothers, "coming off" is often not a permanent exit but a pause — most commonly for pregnancy. GLP-1 medications are not recommended during pregnancy or while breastfeeding, and the current review of their use in pregnancy underscores that they should be stopped before conceiving, with a washout planned in advance rather than improvised⁴. Because each dose lingers roughly a week, the timing is arithmetic you can do ahead of time with a clinician — which is exactly the kind of plan our guide to what to tell your OB before starting is built to start.

A planned pause changes the emotional math too. If you know going in that some regain during a pregnancy is expected biology — not backsliding — you can hold the ground you care about (habits, muscle, the relationship with food) without treating the scale as a verdict. And you can plan the restart on the other side rather than waking up to it.

Check the fine print before you pause, too. If your program runs on a mandatory membership stacked in front of the drug — Regenics charges $79/month before any protocol, on top of the $249 or $399/month protocol itself — confirm whether that membership fee keeps billing through a pause or stops with the medication. A term-length discount is the other thing to check first: Ascend Vitality drops its rate on a 6-month plan, which is real savings if you finish it, but ask what a paused or canceled term actually costs before you sign one.

How to come off well — or decide not to

If you and your clinician decide to stop, a few things genuinely help, and none of them are magic:

1. 1.Taper rather than quit cold, if your clinician agrees. Stepping the dose down can soften the return of appetite instead of flipping it back on all at once.
2. 2.Bank the muscle now. Protein and resistance training during weight loss protect the lean mass that keeps your metabolism up — the same argument we make about the new body and its adjustments. Muscle you keep is regain you resist.
3. 3.Keep the appetite habits you built. The medication taught your kitchen new defaults — smaller portions, protein first, less grazing. Those outlast the drug if you keep practicing them.
4. 4.Decide in advance what triggers a restart. A pre-agreed threshold ("if I regain X, we revisit") turns a shame spiral into a clinical decision.

And sometimes the right answer is not stopping at all. If there is no medical reason to come off, the trials suggest that staying on a maintenance dose is what holds the result — and a program that can hold you steady without the cost climbing every month becomes the thing that matters most. WePeptideRx is a genuine example of the flexibility that decision deserves: its own refund policy states you may cancel or pause anytime, with no hidden fee, confirmed directly from the site's data rather than its marketing copy. QuickMD is built for exactly this kind of pause — no membership to cancel, just a flat $99 visit whenever you want to restart the conversation. Before you decide either way, it is worth understanding the true cost of staying on as the dose climbs, and — if you are weighing which molecule to be on for the long run — our head-to-head on Zepbound vs. Wegovy.

Coming off a GLP-1 is not a finish line, and staying on is not a failure of discipline. Both are clinical decisions, best made on purpose and with a plan — not by the accident of a lapsed prescription.